Preclinical dose assessment of [18F] fluspidine with PET/MRI: Enantiomeric differences in tracer kinetics cause a significant deviation in dosimetry. Kranz, M., Sattler, B., Wuest, N., Deuther-Conrad, W., Fischer, S., Wünsch, B., Steinbach, J., Sabri, O., & Brust, P. Journal of Nuclear Medicine, 56(supplement 3):1025–1025, 2015.
doi  bibtex   
@article{kranz_preclinical_2015,
	Author = {Kranz, Mathias and Sattler, B. and Wuest, Nathanael and Deuther-Conrad, Winnie and Fischer, S. and W{ü}nsch, B. and Steinbach, J{ö}rg and Sabri, Osama and Brust, Peter},
	Doi = {10.3390/molecules21091164},
	Journal = {Journal of Nuclear Medicine},
	Number = {supplement 3},
	Pages = {1025--1025},
	Title = {Preclinical dose assessment of [18F] fluspidine with {PET}/{MRI}: {Enantiomeric} differences in tracer kinetics cause a significant deviation in dosimetry.},
	Volume = {56},
	Year = {2015},
	Bdsk-Url-1 = {https://doi.org/10.3390/molecules21091164}}

Downloads: 0